دورية أكاديمية

Genome-wide DNA Methylation Profiling of Cell-Free Serum DNA in Esophageal Adenocarcinoma and Barrett Esophagus

التفاصيل البيبلوغرافية
العنوان: Genome-wide DNA Methylation Profiling of Cell-Free Serum DNA in Esophageal Adenocarcinoma and Barrett Esophagus
المؤلفون: Rihong Zhai, Yang Zhao, Li Su, Lauren Cassidy, Geoffrey Liu, David C. Christiani
المصدر: Neoplasia: An International Journal for Oncology Research, Vol 14, Iss 1, Pp 29-33 (2012)
بيانات النشر: Elsevier, 2012.
سنة النشر: 2012
المجموعة: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
الوصف: Aberrant DNA methylation (DNAm) is a feature of most types of cancers. Genome-wide DNAm profiling has been performed successfully on tumor tissue DNA samples. However, the invasive procedure limits the utility of tumor tissue for epidemiological studies. While recent data indicate that cell-free circulating DNAm (cfDNAm) profiles reflect DNAm status in corresponding tumor tissues, no studies have examined the association of cfDNAm with cancer or precursors on a genome-wide scale. The objective of this pilot study was to evaluate the putative significance of genome-wide cfDNAm profiles in esophageal adenocarcinoma (EA) and Barrett esophagus (BE, EA precursor). We performed genome-wide DNAm profiling in EA tissue DNA (n = 8) and matched serum DNA (n = 8), in serum DNA of BE (n = 10), and in healthy controls (n = 10) using the Infinium HumanMethylation27 BeadChip that covers 27,578 CpG loci in 14,495 genes. We found that cfDNAm profiles were highly correlated to DNAm profiles in matched tumor tissue DNA (r = 0.92) in patients with EA. We selected the most differentially methylated loci to perform hierarchical clustering analysis. We found that 911 loci can discriminate perfectly between EA and control samples, 554 loci can separate EA from BE samples, and 46 loci can distinguish BE from control samples. These results suggest that genome-wide cfDNAm profiles are highly consistent with DNAm profiles detected in corresponding tumor tissues. Differential cfDNAm profiling may be a useful approach for the noninvasive screening of EA and EA premalignant lesions.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1476-5586
1522-8002
Relation: http://www.sciencedirect.com/science/article/pii/S1476558612800753; https://doaj.org/toc/1476-5586; https://doaj.org/toc/1522-8002
DOI: 10.1593/neo.111626
URL الوصول: https://doaj.org/article/3ddea8134cb54123bc6f6be076a74c4c
رقم الأكسشن: edsdoj.3ddea8134cb54123bc6f6be076a74c4c
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:14765586
15228002
DOI:10.1593/neo.111626